Thoracic Surgery (Cardiothoracic Vascular Surgery) Doctors in Bradenton, FL Accepting Medicare

5 Thoracic Surgery (Cardiothoracic Vascular Surgery) doctors found. Showing 1 - 5

Robert Thrift Ferguson, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 315 75th St W, Bradenton, FL 34209 Phone: 999-999-9999

William V Martinez Jr., MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 5304 4th Avenue Cir E, Bradenton, FL 34208 Phone: 941-744-2640    Fax: 941-744-2650

Dr. Richard James Peterson, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 623 39th St W, Suite 2, Bradenton, FL 34205 Phone: 941-744-2640    Fax: 941-744-2650

Dr. Alessandro Golino, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 5304 4th Avenue Cir E, Bradenton, FL 34208 Phone: 941-744-2640    Fax: 941-744-2650

Dr. Joseph P Alesnik, M.D Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 5304 4th Avenue Cir E, Bradenton, FL 34208 Phone: 941-744-2640    Fax: 941-744-2650

News Archive

Pelotonia Institute for Immuno-Oncology launched at Ohio State to fight cancer at all levels

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute today announced formation of the Pelotonia Institute for Immuno-Oncology, a comprehensive bench-to-bedside research initiative focused on harnessing the body's immune system to fight cancer at all levels-;from prevention to treatment and survivorship.

IHoP may play a critical role in type 1 diabetes

Researchers at Wake Forest Baptist Medical Center's Institute for Regenerative Medicine and colleagues have discovered a new protein that may play a critical role in how the human body regulates blood sugar levels.

Cost of second-line ARVs a 'huge barrier to care' in resource-poor countries

In this U.N. Dispatch blog post, Mark Leon Goldberg, managing editor of the blog, examines the costs of second-line antiretroviral treatments (ARVs), which "are several orders of magnitude more expensive than traditional, first-line ARV treatments" and are a "huge barrier to providing care" for resource-poor countries.

Human Genome Sciences receives FDA approval for Benlysta to treat lupus

The U.S. Food and Drug Administration today approved Benlysta to treat patients with active, autoantibody-positive lupus who are receiving standard therapy, including corticosteroids, antimalarials, immunosuppressives, and nonsteroidal anti-inflammatory drugs.

Public schools can adopt lower physical distancing policies with masking mandates

As COVID-19 infection rates continue to fall, Massachusetts officials are signaling it's almost time to end remote learning and send all school-aged children back to the classroom.

Read more Medical News

› Verified 5 days ago